Across much of Africa, the disease
profile is shifting: while infectious
diseases and maternal child health
remain priorities, non-communicable
conditions especially cancer,
cardiovascular, and neurologic
disease are rising quickly. That shift
demands advanced diagnostic and
treatment capacity: MRI and CT for
accurate diagnosis, PET-CT for staging
and therapy planning, and modern
radiotherapy (LINAC, brachytherapy) for
precise, timely treatment. When these capabilities are absent or unreliable, patients are
diagnosed late, treatments are less effective, and
costs escalate for families and health systems.
Access to advanced imaging and oncology is
concentrated in a handful of urban tertiary centers.
Patients outside capital cities travel long distances,
face long waiting lists, or forgo care altogether.
Referral pathways are fragmented; when a scan
or treatment slot isn’t available, cases are delayed
or diverted to private facilities, increasing outof-pocket costs and pushing some patients into
medical tourism.
88%
Urban–Rural Equity & Referral
Leakage Advanced services cluster in cities, creating
long travel times and delays for rural
patients. When public capacity is full or
down, referrals leak to private or overseas
providers. Strengthening regional hubs
with reliable imaging and radiotherapy
reduces waiting times and keeps care—
and funding—closer to patients.
30%
Reliability Gap: Uptime vs.
Installed Base Installing equipment is not the same as
delivering service. Power conditioning, HVAC
sized to heat loads, shielding, QA routines,
stocked spares, remote diagnostics, and
clear SLAs are what convert assets into daily
clinical availability.
70%
Workforce & Skills Retention Sustainable access depends on people.
Competency ladders for radiographers,
radiation therapists, physicists, and biomedical
engineers—tied to certification and train-thetrainer models—anchor quality over time.
18%+
Medical Growth Even where equipment exists, reliability is the bottleneck. Utilities (power quality, cooling),
spare-parts logistics, and lack of structured maintenance lead to downtime that quietly erodes clinical capacity. Without acceptance
testing, routine QA, and enforceable SLAs,
performance drifts from specification; image
quality, dose control, and treatment accuracy
suffer. Hospitals lose throughput, clinicians lose
confidence, and the public loses trust.
Workforce constraints compound the
gap. Many facilities operate with too
few radiologists, radiation oncologists, medical physicists, and biomedical
engineers to support modern workflows
and QA. Training is often ad hoc and
vendor-specific; when experienced staff
move on, knowledge leaves with them.
Sustainable access requires structured,
certification-aligned training pathways,
train-the-trainer models, and local
service teams equipped with the right
tools and parts.
Finally, financing and procurement
models often emphasize the purchase price over lifecycle performance. Oneoff donor projects and capex-only buys
can leave hospitals with systems they
cannot power, cool, service, or staff. A
better approach is outcome-based: align
budgets to availability, QA pass rates,
and safe throughput, with governance,
indexation, and independent verification
built in. That is the landscape TTM Global
is designed to address.
“Secure by design” means
patch SLAs, backups, and
disaster recovery rehearsed—
not assumed.
About us
TTM Global is a UAE-domiciled
supplier of best-in-class medical
technology, focused on highvalue imaging and oncology
systems for Africa’s public health
sector.
